976
Participants
Start Date
April 30, 2005
Primary Completion Date
January 31, 2009
Study Completion Date
June 30, 2012
Pegylated liposomal doxorubicin
30 mg/m² every 4 weeks during 6 cycles or until progression
Carboplatin
AUC 5 every 3/4 weeks during 6 cycles or until progression
Paclitaxel
175 mg/m² at day 1 every 3 weeks during 6 cycles or until progression
Hôpital Hôtel Dieu, Paris
Collaborators (2)
Schering-Plough
INDUSTRY
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
OTHER
AGO Study Group
OTHER
Australia New Zealand Gynaecological Oncology Group
OTHER
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
NCIC Clinical Trials Group
NETWORK
NSGO
UNKNOWN
ARCAGY/ GINECO GROUP
OTHER